Holger Weis
Net worth: 58 076 $ as of 2026-06-29
Net worth: 58 076 $ as of 2026-06-29
Holger Weis is the founder of Weis Advisors, Inc., founded in 2018, serving as President & Principal.
Current jobs include Chairman & Chief Executive Officer at Alaunos Therapeutics, Inc. since 2025 and Independent Director at Jupiter Neurosciences, Inc. since 2021.
Former jobs include Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021;.
Senior Manager at Ernst & Young LLP from 1986 to 2000; Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005; President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017; Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010; and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011.
Education includes an undergraduate degree from the University of Georgia, conferred in 1985.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-29 | 16,552 ( 0.68% ) | 37 408 $ | 2026-06-29 | |
| 2026-06-01 | 96,581 ( 0.2% ) | 20 668 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Executive Officer | 2025-07-01 |
| JUPITER NEUROSCIENCES, INC. | Director/Board Member | 2021-09-07 |
Weis Advisors, Inc. | Founder | 2018-03-31 |
| Companies | Position | End |
|---|---|---|
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Director of Finance/CFO | 2021-02-28 |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | President | 2017-07-23 |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Director of Finance/CFO | 2011-10-31 |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Director of Finance/CFO | 2010-07-31 |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Director of Finance/CFO | 2004-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Health Technology |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Health Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Commercial Services |
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Weis Advisors, Inc. | |
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Select your edition
All financial news and data tailored to specific country editions